The Potential Clinical Benefit of Tocilizumab Therapy for Patients With HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review

Cureus
doi 10.7759/cureus.7589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Multicentric Cutaneous Crohn's Disease: A Case Report and Review of Literature

Canadian Journal of Gastroenterology
1990English

Siltuximab: A Targeted Therapy for Idiopathic Multicentric Castleman Disease

Immunotherapy
OncologyAllergyImmunology
2016English

FDA Approval: Siltuximab for the Treatment of Patients With Multicentric Castleman Disease

Clinical Cancer Research
Cancer ResearchOncology
2015English

Is Tocilizumab a Potential Therapeutic Option for Refractory Unicentric Castleman Disease?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cutaneous Plasmacytosis Treated With Tocilizumab: A Case Report and Review of the Literature

Madridge Journal of Dermatology & Research
2016English

Clinicopathologic Characteristics of 342 Patients With Multicentric Castleman Disease in Japan

Modern Rheumatology
MedicineRheumatology
2020English

Human Herpesvirus-8 Negative Multicentric Castleman Disease in a Patient With Human Immunodeficiency Virus Treated With Highly Active Antiretroviral Therapy and Chemotherapy

Cureus
2019English

Non-Aids-Related Primary Intraosseous Kaposi's Sarcoma: Case Report and Literature Review

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1997English

HHV-8-Related Three Malignancies in an Immunocompetent Patient: Kaposi Sarcoma, Multisentric Castleman Disease and Primary Effusion Lymphoma

Turkiye Klinikleri Journal of Case Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy